Reductions in health-related quality of life in patients with ankylosing spondylitis and improvements with etanercept therapy
- 15 August 2005
- journal article
- clinical trial
- Published by Wiley in Arthritis & Rheumatism
- Vol. 53 (4) , 494-501
- https://doi.org/10.1002/art.21330
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Etanercept treatment of psoriatic arthritis: Safety, efficacy, and effect on disease progressionArthritis & Rheumatism, 2004
- Quality of life and work in patients with rheumatoid arthritis and ankylosing spondylitis of working ageAnnals of the Rheumatic Diseases, 2003
- Recombinant human tumor necrosis factor receptor (etanercept) for treating ankylosing spondylitis: A randomized, controlled trialArthritis & Rheumatism, 2003
- Six‐month results of a double‐blind, placebo‐controlled trial of etanercept treatment in patients with active ankylosing spondylitisArthritis & Rheumatism, 2003
- Disease-modifying antirheumatic drug therapy for spondyloarthropathiesCurrent Opinion in Rheumatology, 2003
- Comparative cytokine gene expression in synovial tissue of early rheumatoid arthritis and seronegative spondyloarthropathiesRheumatology, 1997
- Patterns of expression of tumor necrosis factor α, tumor necrosis factor β, and their receptors in synovia of patients with juvenile rheumatoid arthritis and juvenile spondylarthropathyArthritis & Rheumatism, 1996
- Use of immunohistologic and in situ hybridization techniques in the examination of sacroiliac joint biopsy specimens from patients with ankylosing spondylitisArthritis & Rheumatism, 1995
- SERUM CYTOKINES (IL-6, TNF-α, IL-1β AND IFN-γ) IN ANKYLOSING SPONDYLITIS: A CLOSE CORRELATION BETWEEN SERUM IL-6 AND DISEASE ACTIVITY AND SEVERITYRheumatology, 1994
- Evaluation of Diagnostic Criteria for Ankylosing SpondylitisArthritis & Rheumatism, 1984